Aureus Asset Management Llc increased Idexx Labs Inc Com (IDXX) stake by 70.82% reported in 2017Q2 SEC filing. Aureus Asset Management Llc acquired 3,150 shares as Idexx Labs Inc Com (IDXX)’s stock rose 13.64%. The Aureus Asset Management Llc holds 7,598 shares with $1.23 million value, up from 4,448 last quarter. Idexx Labs Inc Com now has $13.87 billion valuation. The stock decreased 0.43% or $0.69 during the last trading session, reaching $159.01. About 84,864 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since December 12, 2016 and is uptrending. It has outperformed by 66.60% the S&P500.
Among 8 analysts covering Emera Inc. (TSE:EMA), 3 have Buy rating, 0 Sell and 5 Hold. Therefore 38% are positive. Emera Inc. had 37 analyst reports since August 12, 2015 according to SRatingsIntel. The company was maintained on Tuesday, November 17 by RBC Capital Markets. The company was initiated on Tuesday, September 29 by National Bank Canada. Raymond James maintained Emera Incorporated (TSE:EMA) on Thursday, September 22 with “Market Perform” rating. The rating was upgraded by IBC on Wednesday, August 12 to “Sector Outperformer”. On Tuesday, November 8 the stock rating was maintained by RBC Capital Markets with “Outperform”. The rating was maintained by Scotia Capital with “Sector Perform” on Wednesday, August 12. The rating was maintained by Desjardins Securities with “Buy” on Thursday, November 24. TD Securities maintained Emera Incorporated (TSE:EMA) rating on Wednesday, August 12. TD Securities has “Hold” rating and $47 target. The firm earned “Market Perform” rating on Tuesday, September 29 by BMO Capital Markets. The firm has “Market Perform” rating given on Thursday, April 13 by Wells Fargo. See Emera Incorporated (TSE:EMA) latest ratings:
06/12/2017 Broker: Scotia Capital Rating: Sector Perform Old Target: $50.00 New Target: $51.00 Target Up
29/09/2017 Broker: IBC Rating: Old Target: $54.00 New Target: $56.00 Target Up
Among 9 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 5 have Buy rating, 2 Sell and 2 Hold. Therefore 56% are positive. IDEXX Laboratories had 22 analyst reports since July 24, 2015 according to SRatingsIntel. The company was initiated on Thursday, February 4 by Credit Suisse. The firm has “Buy” rating given on Friday, July 28 by C.L. King. Stifel Nicolaus maintained it with “Buy” rating and $185.0 target in Monday, August 21 report. The firm has “Sell” rating by Feltl & Co given on Friday, February 3. The rating was maintained by Stifel Nicolaus on Thursday, October 29 with “Buy”. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Bank of America on Wednesday, August 23. The firm earned “Buy” rating on Wednesday, July 20 by Canaccord Genuity. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Canaccord Genuity on Tuesday, June 13. On Monday, October 23 the stock rating was maintained by Stifel Nicolaus with “Buy”. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, July 23.
Investors sentiment decreased to 0.86 in 2017 Q2. Its down 0.33, from 1.19 in 2017Q1. It turned negative, as 28 investors sold IDXX shares while 184 reduced holdings. 86 funds opened positions while 167 raised stakes. 76.34 million shares or 0.83% less from 76.98 million shares in 2017Q1 were reported. City accumulated 0% or 56 shares. Telemus Capital Limited Liability Company accumulated 6,000 shares or 0.13% of the stock. The New Hampshire-based Wendell David Assocs has invested 1.14% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). 400 are owned by One Trading L P. 1,992 were accumulated by Parkwood Limited Liability Company. Amer Century Companies holds 480,978 shares. Moreover, Ahl Prtn Llp has 0.07% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 20,106 shares. Natixis has invested 0.27% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Vanguard Grp holds 0.07% or 9.26M shares. Comerica Comml Bank owns 30,686 shares. Dorsey Wright Associate reported 21,567 shares or 1.36% of all its holdings. Jefferies Gru holds 0.05% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 45,084 shares. Macquarie Group Limited accumulated 35,500 shares. Van Eck Associates Corporation holds 158,130 shares or 0.14% of its portfolio. Somerville Kurt F owns 2,500 shares for 0.08% of their portfolio.
Aureus Asset Management Llc decreased Raytheon Co Com New (NYSE:RTN) stake by 1,988 shares to 4,009 valued at $647,000 in 2017Q2. It also reduced Dow Chem Co Com (NYSE:DOW) stake by 6,800 shares and now owns 8,869 shares. Boston Scientific Corp Com (NYSE:BSX) was reduced too.
The stock decreased 0.25% or $0.12 during the last trading session, reaching $48.08. About 91,881 shares traded. Emera Incorporated (TSE:EMA) has 0.00% since December 12, 2016 and is . It has underperformed by 16.70% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.